ClinConnect ClinConnect Logo
Search / Trial NCT01196182

Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)

Launched by CHILDREN'S HOSPITAL MEDICAL CENTER, CINCINNATI · Sep 3, 2010

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

ClinConnect Summary

The Congenital Heart Disease GEnetic NEtwork Study (CHD GENES) is a research study focused on understanding the genetic causes of congenital heart defects (CHD), which are heart problems present at birth and affect about 8 out of every 1,000 babies. This study aims to collect DNA and health information from participants to better understand how genes may influence the severity and outcomes of these heart defects. By doing this, researchers hope to find common genetic factors that contribute to CHD and how they may impact patients' health.

Anyone interested in joining the study needs to provide a signed consent form. However, some individuals won't qualify, such as those with specific minor heart conditions like isolated patent foramen ovale or certain types of heart issues related to premature birth. Participants will have their genetic material collected and will be asked questions about their health, which will help researchers gather detailed information to make important discoveries about congenital heart disease. This is an exciting opportunity to contribute to research that could lead to better treatments and outcomes for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Signed consent form
  • Exclusion Criteria:
  • Isolated patent foramen ovale
  • Isolated prematurity-associated patent ductus arteriosus

About Children's Hospital Medical Center, Cincinnati

Children's Hospital Medical Center in Cincinnati is a leading pediatric healthcare institution dedicated to advancing child health through innovative clinical research and comprehensive patient care. Renowned for its commitment to excellence, the center conducts a wide range of clinical trials aimed at developing and evaluating new treatments and therapies for pediatric populations. With a focus on multidisciplinary collaboration and ethical research practices, Children's Hospital Medical Center strives to improve health outcomes for children while contributing to the broader scientific understanding of pediatric medicine.

Locations

New Haven, Connecticut, United States

New York, New York, United States

New York, New York, United States

Boston, Massachusetts, United States

Boston, Massachusetts, United States

Los Angeles, California, United States

Rochester, New York, United States

Palo Alto, California, United States

Philadelphia, Pennsylvania, United States

Salt Lake City, Utah, United States

Salt Lake City, Utah, United States

San Francisco, California, United States

London, England, United Kingdom

New Haven, Connecticut, United States

New Hyde Park, New York, United States

Patients applied

0 patients applied

Trial Officials

Amy Roberts, MD

Principal Investigator

Childrens Hospital Boston

Christine Seidman, MD

Principal Investigator

Harvard Medical School, Boston MA

Bruce Gelb, MD

Principal Investigator

Mt Sinai School of Medicine, New York NY

Martina Brueckner, MD

Principal Investigator

Yale University

Martin Tristani-Firouzi, MD

Principal Investigator

University of Utah

Wendy Chung, MD, PhD

Principal Investigator

Columbia University Medical Center, New York NY

Jon Cleveland

Principal Investigator

Children's Los Angeles

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials